Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Galderma Research x26 Development
Galderma Research x26 Development Snc
Galderma Research x26 Development S n c
Galderma Research x26 Development Biot France
Galderma Research x26 Development_20100114
Galderma Research x26 Development_20131212
Galderma Research x26 Development_20100128
  

Galderma Research & Development patents

Recent patent applications related to Galderma Research & Development. Galderma Research & Development is listed as an Agent/Assignee. Note: Galderma Research & Development may have other listings under different names/spellings. We're not affiliated with Galderma Research & Development, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "G" | Galderma Research & Development-related inventors




Date Galderma Research & Development patents (updated weekly) - BOOKMARK this page
09/21/17Skin organ culture model system and its use
08/31/17Benzenesulfonamide compounds, synthesizing same, and use thereof in medicine and cosmetics
08/17/17Micrornas characterizing rosacea and the uses thereof
08/10/17Micrornas characterizing acne and the uses thereof
08/03/17Combination of adapalene and benzoyl peroxide for the treatment of severe acne
08/03/17Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris
07/20/17Combination/association of adapalene and benzoyl peroxide for treating acne
06/29/17Method for the treatment of acne using pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid
06/22/17Leave-in chemical foam comprising benzoyl peroxide
06/22/17Rinse-off chemical mousse containing benzoyl peroxide
05/11/17Antibodies against human sodium channel nav1.9 and uses thereof for the diagnosis of inflammatory skin diseases
04/06/17Combination of adapalene and benzoyl peroxide for the treatment of severe acne
03/16/17Method of analyzing facial images for detecting a flush effect
03/09/17N-(pyrid-4-yl)amides and n-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use
02/23/17Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
02/09/17Novel phenol derivatives and pharmaceutical or cosmetic use thereof
02/02/17Use of naratriptan in the treatment of rosacea
01/26/17Method for treating and/or preventing acne scars with a fixed combination of adapalene or its salts and benzoyl peroxide
01/26/17Human epithelial cell line for 3-d modelizing of cancer and treatment thereof
01/05/17Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
12/15/16Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
12/15/16Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
12/01/16Pulse photodynamic treatment of skin conditions
11/24/16Pulse photodynamic treatment of acne
11/24/16Modulators of the nav 1.9 sodium channel for treating an inflammatory skin disease and diagnostic methods
11/10/16Ovol1 as a new marker for moderate to severe acne
11/10/16Th17 differentiation markers for acne and uses thereof
11/03/16Ap5b1 as a new marker for moderate to severe acne
10/27/16Lipid microcapsules preferably comprising a retinoid, and composition containing same, the production thereof, and use of same in dermatology
10/27/16Therapy regimen for treating severe acne related diseases
10/20/16Lipid microcapsules preferably comprising a lipophilic active substance and composition containing same, the production thereof, and use of same in dermatology and in cosmetics
10/06/16Pulse photodynamic treatment of photodamaged skin
09/29/16Novel benzenesulfonamide compounds, synthesizing same, and use thereof in medicine as well as in cosmetics
08/18/16Method for evaluating the severity of atrophic acne scars on a patient and device used to evaluate the distribution of acne scars
08/18/16Oxazetidine derivatives, process for preparing them and use in human medicine and in cosmetics
08/18/16Th17 differentiation markers for acne and uses thereof
06/30/16Method for the synthesis of 4-(heterocycloalkyl)-benzene-1,3,-diol compounds
06/16/16Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
06/16/16Method for treating skin thickening
05/26/16Maintenance therapy regime/regimen for the treatment of acne
04/28/16Novel phenol derivatives and pharmaceutical or cosmetic use thereof
04/28/16Use of a slc mammalian skin transporter
04/07/16Methods and compositions for safe and effective treatment of erythema
03/10/16Phenol derivatives and the pharmaceutical or cosmetic use thereof
02/25/16Method for measuring flushing and use for assessing treatments
02/25/16Method for detecting trichophytons and associated diseases
01/07/16Modulators and methods for the treatment of rosacea
12/31/15Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies
12/31/15Method for the synthesising 4-piperidin-4-yl-benzene-1,3-diol and the salts of same and novel compound tert-butyl 4-(2,4-dihydroxy-phenyl)-4-hydroxy-piperidine-1-carboxylate
12/03/15Dermatological compositions comprising at least one retinoid compound, an anti-irritant compound and benzoyl peroxide
11/19/15Melanocortin receptor antagonist compounds, process for preparing them and use thereof in human medicine and cosmetics
11/12/15Injectable combination of adrenergic receptor agonists with fillers, for decreasing skin reactions due to injection
11/05/15Method for treating cell proliferation disorders
10/29/15Method for the diagnosis of rosacea
10/22/15New stable anesthetic composition for reducing skin reactions
08/06/15Pharmaceutical/cosmetic, e.g., anti-acne compositions comprising at least one naphtoic acid compound, benzoyl peroxide and at least one film-forming agent
07/30/15Methods and compositions for safe and effective treatment of erythema
07/23/15Combination therapy for acne vulgaris comprising administration of adapalene 0.3% gel and clindamycin/benzoyl peroxide gel
07/09/15Selective compounds inhibiting cyp26a1 useful in cosmetic and pharmaceutical compositions
07/09/15Process for preparing a dermatological composition comprising oleosomes
07/09/15Topical compositions in the form of a gel containing a particular solubilized retinoid
07/09/15Microcapsules containing retinoids, preparing same, and pharmaceutical compositions containing same
07/09/154-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
06/11/15Novel benzenesulfonamide compounds, synthesizing same, and use thereof in medicine as well as in cosmetics
06/04/15Topical compositions of aqueous gel type in the form of a homogeneous suspension of an active principle of the retinoid class containing at least one hydrophobic silica
Patent Packs
05/28/15Dermatological composition comprising oleosomes and retinoids, process for preparing the same and use thereof
05/28/15O/w-emulsion-type topical pharmaceutical compositions containing a retinoid
05/07/15Lipid nanocapsules comprising a retinoid, nanodispersion and composition containing the same, process for preparing the same and use thereof in dermatology
05/07/15Treatment of preadolescent moderate acne vulgaris
04/30/15Optimizing ungual treatment by quantitative autoradiography
04/09/15Method for preventing or treating skin tumor
04/09/15Cream gels comprising at least one retinoid and benzoyl peroxide
03/26/15Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
02/12/15Method for the treatment of acne using pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid
02/12/15Oxoazetidine derivatives, process for the preparation thereof and use thereof in human medicine and in cosmetics
02/12/15Combination of a mc1r receptor agonist and uvb for the treatment and/or prevention of pigmentation disorders
12/18/14Combination of a prostaglandin receptor agonist and an mc1r receptor agonist for the treatment and/or prevention of pigmentation disorders
12/18/14Combination therapy for acne vulgaris comprising administration of adapalene 0.3% gel and clindamycin/benzoyl peroxide gel
12/18/144-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
11/27/14New th-17 differentiation markers for rosacea and uses thereof
Patent Packs
11/06/14New leukocyte infiltrate markers for rosacea and uses thereof
10/16/14Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
10/02/14Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
09/18/14Novel benzenesulfonamide compounds, synthesizing same, and use thereof in medicine as well as in cosmetics
09/18/14Novel phenol derivatives and pharmaceutical or cosmetic use thereof
09/04/14Combination of compounds for treating or preventing skin diseases
09/04/14Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
08/21/14N-(pyrid-4-yl)amides and n-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use
08/07/14Th-17 differentiation markers for rosacea and uses thereof
07/24/14New stable anesthetic composition for reducing skin reactions
07/03/144-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
06/12/14In vitro method using human skin for evaluating the influence of abc transporters
05/29/14Compositions comprising a filler product and a compound of the tetracycline family used at a subantimicrobial dose
05/22/14Pharmaceutical/cosmetic compositions comprising hyaluronic acid and treatment of dermatological conditions therewith
04/17/14Novel benzenesulfonamide compounds, synthesizing same, and use thereof in medicine as well as in cosmetics
04/03/14Methods and compositions for safe and effective treatment of erythema
03/06/14Compositions comprising a filler product and at least one bioresorbable and biodegradable silica-based material
01/30/14Modulators and methods for the treatment of rosacea
01/30/14Combinations of adapalene and benzoyl peroxide for treating acne lesions
01/09/14Dermatological compositions comprising retinoids, dispersed benzoyl peroxide and carrageenans
12/26/13Determination by independent component analysis of the efficacy of a treatment
12/19/13Dermatological foams obtained from a gel or suspension containing benzoyl peroxide
12/12/13Topical compositions containing a retinoid of the oil-in-water emulsion type
11/28/13Dermatological foams obtained from a gel or suspension containing a combination of adapalene and benzoyl peroxide
09/26/13Combinations of adapalene and benzoyl peroxide for treating acne lesions
09/19/13Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers
09/05/13Use of squaramide in the prevention and/or treatment of rosacea
08/22/13Metronidazole esters for treating rosacea
08/08/13Method for treating scars with adapalene 0.3%
08/01/13Metronidazole esters for treating rosacea
Social Network Patent Pack
07/11/13Phenol derivatives and the pharmaceutical or cosmetic use thereof
07/11/13Derivatives of novel peroxides, preparation thereof and use thereof in human medicine as well as in cosmetics for the treatment or prevention of acne
07/04/13Novel benzenesulfonamide compounds, synthesizing same, and use thereof in medicine as well as in cosmetics
07/04/13Phenol derivatives and pharmaceutical or cosmetic use thereof
06/20/13Metronidazole esters for treating rosacea
05/30/13Pharmaceutical/ cosmetic composition comprising hyaluronic acid and treatment of dermatological conditions therewith
05/23/13Use of a dermatological composition comprising a combination of adapalene and benzoyl peroxide which is intended for the treatment of acne in non-caucasian population with decrease of post-inflammatory hyperpigmentation
05/09/13Combination therapy for treating or preventing an inflammatory skin disorder
03/28/13Dibenzoyl peroxide derivatives, preparation method thereof and cosmetic or dermatological compositions containing same
02/21/13Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
Patent Packs
02/14/13Dermatological compositions comprising at least one reinoid compound, an anti-irritant compound and benzoyl peroxide
02/14/13Topical application of adapalene for the long-term treatment of acne vulgaris
01/24/134-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
01/17/13Markers and the diagnosis of rosacea
01/03/13Use of compounds in the treatment or prevention of skin disorders
12/20/12Use of a dipyridyl compound for treating rosacea
12/20/12Novel benzenesulfonamide compounds, synthesizing same, and use thereof in medicine as well as in cosmetics
12/20/124-(azacycloalkyl) -benzene-1,3-diol derivatives as tyrosinase inhibitors and their synthesis and use thereof
12/20/12Novel peroxide derivatives, their process of preparation and their use in human medicine and in cosmetics for the treatment or prevention of acne
12/06/12Method of dissolving antifungal agent, and compositions with a high concentration of antifungal agent, suitable for application to the nail
11/22/12Combination of adrenergic receptor agonist alpha-1 or alpha-2, preferably brimonidine with fillers, preferably hyaluronic acid
11/08/12Dermatological/cosmetic skin depigmenting compositions
10/25/12Topical application of travoprost for combating hair loss
10/11/12Novel ligands that modulate rar receptors
09/06/124-alkoxy-n- (2-hydroxycarbamoyl-2-piperidinyl-ethyl) -benzamide compounds as selective tace-inhibitors for the treatment of inflammatory diseases
08/23/12Novel ligand activators of the rar receptors and pharmaceutical/cosmetic applications thereof
07/12/12N- [2-hydroxycarbamoyl-2- (piperazinyl) ethyl] benzamide compounds, their preparation and their use as tace inhibitors
05/31/12Combinations of adapalene and benzoyl peroxide for treating acne lesions
05/17/12Novel biaromatic compounds that modulate ppary type receptors and cosmetic/pharmaceutical compositions comprised thereof
05/17/12Infrared imaging of cutaneous melanoma
05/10/12Combination/association of adapalene and benzoyl peroxide for treating acne lesions
03/29/12Method for preparing molecular complexes between adapalene and cyclodextrins
03/08/12Combinations of adapalene and benzoyl peroxide for treating acne lesions
03/01/12Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
02/23/12Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
02/16/124-(heterocycloalkyl) benzene -1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
02/09/12Combination of compounds for treating or preventing skin diseases
01/26/12Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
01/26/12N-phenylacetamide derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
01/19/12Biphenyl compound selective agonists of gamma rar receptors
Patent Packs
12/29/11Dermatological/cosmetic compositions comprising a retinoid and benzoyl peroxide
12/29/11Anhydrous depigmenting compositions comprising, within the fatty phase thereof, a solubilized phenolic compound and a retinoid
12/22/11Novel 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
12/15/11Anhydrous petroleum jelly/elastomer-free depigmenting compositions comprising a solubilized phenolic compound
11/17/11Melanocortin receptor antagonist compounds, process for preparing them and use thereof in human medicine and cosmetics
11/10/11Oxoazetidine derivatives, process for the preparation thereof and use thereon in human medicine and in cosmetics
11/10/11Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide
11/10/11Depigmenting topical compositions and their uses
11/10/11Sox modulators in the treatment of alopecia
11/10/11Melanocortin receptor modulators, process for preparing them and use there in human medicine and cosmetics
11/03/11Pctp modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
10/27/11Gos2 modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
10/20/11Cosmetic/dermatological compositions comprising naphtholic acid compounds and polyurethane polymers
09/29/11Lgr5 modulators in the treatment of alopecia
09/22/11Pacap signaling pathway modulators for treating inflammatory skin diseases having a neurogenic component, notably rosacea, and compositions comprised thereof
09/15/11Fzd2 molulators in the treatment of alopecia
09/08/11Amorolfine patch for the treatment of onychomycosis
09/01/11Adfp modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
08/04/11Screening for modulators of cyp2b15 and/or gpd1 for the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
07/28/11Concurrent therapy regime/regimen for the treatment of acne related diseases
Social Network Patent Pack
07/07/11Cidea modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
06/23/11Modulators of carnitine octanoyltransferase in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
06/23/11Modulators of acetyl-coenzyme a acyltransferase 1 or 2 in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
06/23/11Screening for modulators of ces1 and/or ces3 for the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
06/23/11Anhydrous petroleum jelly/elastomer-free depigmenting compositions comprising a solubilized phenolic compound and a retinoid
06/16/11Maintenance therapy regime/regimen for the treatment of acne
06/09/11Pharmaceutical/cosmetic, e.g., anti-acne compositions comprising at least one naphthoic acid compound, benzoyl peroxide and at least one film-forming agent
06/02/11Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
03/24/11Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid
03/24/11Dermatological/cosmetic gels comprising at least one retinoid and benzoyl peroxide
02/03/11Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
01/06/11Dermatological compositions comprising retinoids, dispersed benzoyl peroxide and carrageenans
11/18/10Novel ligands that modulate rar receptors
11/11/10Pharmaceutical composition comprising oleaginous ointments and vitamin d or its derivatives in the solubilized state
11/11/10Method for the synthesis of (z)-3-[2-butoxy-3'-(3-heptyl-1-methyl-ureido)-biphenyl-4-yl]-2-methoxy-acrylic acid
11/04/10Production of adapalene gels
10/28/10Novel n-phenylacetamide inhibitors of the enzyme soat-1 and pharmaceutical/cosmetic compositions comprised thereof
10/28/10Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid
10/28/10Novel ligand activators of the rar receptors and pharmaceutical/cosmetic applications thereof
10/14/10Egr1 modulators for the treatment of alopecia
Social Network Patent Pack
10/14/10Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics
09/30/10Compounds that modulate ppar gamma-type receptors and cosmetic/pharmaceutical compositions comprising said compounds
09/30/10Novel n-phenylacetamide inhibitors of the enzyme soat-1 and pharmaceutical/cosmetic compositions comprised thereof
09/16/10Non-invasive technique for conducting skin inflammatory disease pharmaco-genomic studies and diagnoses thereof
09/02/10Excipient preservatives and pharmaceutical compositions comprised thereof
09/02/10Novel phenylurea inhibitors of the soat-1 enzyme and pharmaceutical/cosmetic compositions comprised thereof
08/19/10Delivery of therapeutically/dermatologically active species into the skin via electroporation
08/05/10Novel phenylurea inhibitors of the enzyme soat-1 and pharmaceutical/cosmetic compositions comprised thereof
07/29/10Topical application of travoprost for combating hair loss
07/22/10Dermatological compositions comprising at least one retinoid compound, an anti-irritant compound and benzoyl peroxide
07/15/10Pactimibe medicaments for preventing/treating a disease due to sebaceous gland dysfunction in humans or animals
07/08/10Eflucimibe medicaments for preventing/treating a disease due to sebaceous gland dysfunction in humans or animals
07/01/10Cream gels comprising at least one retinoid and benzoyl peroxide
07/01/10Utilization of tace inhibitors for the treatment of acne
07/01/10Target enzyme for the treatment of acne
07/01/10Treatment of acne disease states, notably acne vulgaris
06/24/10Novel 3-phenylpropanoic compound activators of receptors of ppar type and pharmaceutical/cosmetic compositions comprised thereof
06/24/10Dermatological compositions comprising at least one retinoid compound, an anti-irritant compound and benzoyl peroxide
06/10/10Dermatological/cosmetic skin depigmenting compositions
06/10/10Novel skin moisturizing compositions
06/10/10Novel 4-heteroarylimidazole-2-thione tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof
06/10/10Novel 4-phenylimidazole-2-thione tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof
06/10/10Novel 3-phenyl acrylic acid compound activators of type ppar receptors and pharmaceutical/cosmetic compositions comprised thereof
06/10/10Novel phenylboronic acid compounds and intermediates and processes for the preparation thereof
05/27/10Administration of adapalene for modulating the expression of cd1d or il-10
05/27/10Administration of adapalene for modulating the expression of il-1ra
05/20/10Topical application of fluocinolone acetonide for depigmentation of the skin
04/22/10Methods of modulating ppar gamma-type receptors
04/08/10Novel phenylboronic acid compounds and intermediates and processes for the preparation thereof
03/18/10Topical application of adapalene for the long-term treatment of acne vulgaris
Social Network Patent Pack
03/04/10Corrective methodology for processing results of transcriptome experiments obtained by differential analysis
02/11/10Methods for activating ppar gamma-type receptors
02/04/10Modulators of udp-glucose ceramide glucosyltransferase for treating acne or hyperkeratinization
02/04/10Modulators of hsd17b7 for treating acne or hyperseborrhea
01/28/10Modulators of sc4mol for treating acne or hyperseborrhea
01/28/10Modulators of lanosterol synthetase for treating acne or hyperseborrhea
01/28/10Dermatological/cosmetic compositions comprising a retinoid and benzoyl peroxide
01/14/10Novel tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof
12/24/09Emulsions comprising at least one retinoid and benzoyl peroxide
12/10/09Online protocol/tool for evaluating acne lesions
12/03/09Modulators of elovl5 for treating acne or hyperseborrhea
12/03/09Combinations of adapalene and benzoyl peroxide for treating acne lesions
11/12/09Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders
10/15/09Modulators of the transporter abcd3 for treating acne or hyperseborrhea
10/08/09Combinations of adapalene and benzoyl peroxide for treating acne lesions
10/01/09Modulators of scarb-1 for treating acne or hyperseborrhea
07/30/09Reduced-irritant dermatological compositions comprising at least one naphthoic acid compound and benzoyl peroxide and treatment of keratinization disorders therewith
05/28/09Administration of (3s)-n-hydroxy-4-(sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide or (s)-n_hydroxy-4-[4_(but-2-ynyloxy)phenylsulfonyl]-2,2-dimethyl thimomorpholine-3-carboxamide for preventing and/or treating inflammatory skin pathologies/afflictions
04/16/09Cosmetic/pharmaceutical compositions comprising retinoids and anti-irritants and treatment of keratinization disorders therewith
03/05/09Novel biaromatic compounds which activate ppary type receptors and cosmetic/pharmaceutical compositions comprised thereof
02/19/09Administration of tropisetron for treating inflammatory skin diseases/disorders
02/05/09Biphenyl compound selective agonists of gamma rar receptors
12/12/13Topical compositions containing a retinoid of the oil-in-water emulsion type
01/28/10Dermatological/cosmetic compositions comprising a retinoid and benzoyl peroxide
01/14/10Novel tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof
08/28/14Combinations of indigo naturalis and berberine and uses thereof
09/26/13Method for preventing or treating skin tumor
09/19/13Method for preventing or treating skin tumor
07/25/13Combination of compounds for treating or preventing skin diseases







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Galderma Research & Development in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Galderma Research & Development with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';